FDA Authorizes Marketing of Sequencing Test for HIV Mutations
Monitoring of viral loads remains critical to treatment The U.S. Food and Drug Administration authorized marketing of a test to detect human immunodeficiency virus (HIV) Type-1 drug resistance mutations using next generation sequencing (NGS) technology. The Sentosa SQ HIV Genotyping Assay is the first…